CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Beginning Balance (shares) at Sep. 30, 2017		11,767,000
Beginning Balance at Sep. 30, 2017	$ 35,855	$ 12	$ 82,687	$ (46,844)
Directors' stock grants and expense (in shares)		93,000
Stock-based compensation	1,169		1,169
Exercise of stock options (shares)		39,000
Exercise of stock options	46		46
Net income	79			79
Ending Balance (shares) at Jun. 30, 2018		11,899,000
Ending Balance at Jun. 30, 2018	37,455	$ 12	84,079	(46,636)
Beginning Balance (shares) at Mar. 31, 2018		11,899,000
Beginning Balance at Mar. 31, 2018	35,600	$ 12	83,838	(48,250)
Stock-based compensation	241		241
Net income	1,614			1,614
Ending Balance (shares) at Jun. 30, 2018		11,899,000
Ending Balance at Jun. 30, 2018	$ 37,455	$ 12	84,079	(46,636)
Beginning Balance (shares) at Sep. 30, 2018	11,899	11,899,000
Beginning Balance at Sep. 30, 2018	$ 39,418	$ 12	84,285	(44,879)
Directors' stock grants and expense (in shares)		102,000
Stock-based compensation	$ 591		591
Exercise of stock options (shares)	35,000	35,000
Exercise of stock options	$ 39		39
Net income	$ 3,758			3,758
Ending Balance (shares) at Jun. 30, 2019	12,036	12,036,000
Ending Balance at Jun. 30, 2019	$ 43,806	$ 12	84,915	(41,121)
Beginning Balance (shares) at Mar. 31, 2019		12,036,000
Beginning Balance at Mar. 31, 2019	42,804	$ 12	84,716	(41,924)
Stock-based compensation	199		199
Net income	$ 803			803
Ending Balance (shares) at Jun. 30, 2019	12,036	12,036,000
Ending Balance at Jun. 30, 2019	$ 43,806	$ 12	$ 84,915	$ (41,121)